Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (TVTX), sold 1,407 shares at $17.12 ($24K) on 2021-08-17, disclosed to the SEC on 2021-08-17.
Open-market sale of $24k TVTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |